A new triazolyl‐indolo‐quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPεC
Drug Development Research · 2023
DOI: 10.1002/ddr.22117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2023. Verfasst von Rajaghatta N Suresh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore, India. Hauptthemen laut MEDLINE: Signal Transduction, Stomach Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Signal transducer and activator of transcription 3 (STAT3) and STAT5 are the transcription factors that have been studied extensively in relevance to the development of cancers in humans. Suppression of either STAT3 or STAT5‐mediated signaling events has been demonstrated to be effective in inducing cytotoxicity in cancer cells. Herein, new hybrids of triazolyl‐indolo‐quinoxaline are synthesized and examined for their effect on the activation of STAT3 and STAT5 pathways in gastric cancer (GC) cells. Among the newly synthesized compounds, 2,3‐difluoro‐6‐((1‐(3‐fluorophenyl)‐1H‐1,2,3‐triazol‐5‐yl)methyl)‐6H‐indolo[2,3‐b]quinoxaline (DTI) displayed selective cytotoxicity against GC cells over their normal counterpart. Flow cytometric analysis, annexin‐V‐fluorescein isothiocyanate staining, terminal deoxynucleotidyl transferase dUTP nick end labeling assay, live and dead assay, and caspase activation experiments suggested DTI as a potent inducer of apoptosis. The mechanistic approach revealed that DTI imparts cytotoxicity via downregulating the phosphorylation of STAT3 Y705 and STAT5 Y694/699 . DTI significantly reduced the nuclear pool of STAT3/STAT5 and reduced the DNA interaction ability of STAT3/STAT5 as evidenced by immunofluorescence and electrophoretic mobility shift assay. Further investigation revealed that inhibitory effects towards STAT proteins were mediated through the suppression of upstream kinases such as JAK1, JAK2, and Src. Treatment of GC cells with pervanadate counteracted the DTI‐driven STAT3/STAT5 inhibition suggesting the involvement of tyrosine phosphatase. Upon DTI exposure, there was a significant upregulation in the mRNA and protein expression of PTPεC, which is a negative regulator of the JAK‐STAT pathway. Knockdown of PTPεC suppressed the DTI‐induced STATs inhibition in GC cells. Taken together, triazolyl‐indolo‐quinoxaline is presented as a new inhibitor of the STAT3/STAT5 pathway in GC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore, India.
- Department of Science in Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
- Department of Studies in Molecular Biology, University of Mysore, Mysore, India.
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
ORCID-Profile: Gautam Sethi
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Suresh, R. N., Jung, Y. Y., Mohan, C. D., Gowda, S. V., Harsha, K. B., Mantelingu, K., Sethi, G., Ahn, K. S., & Rangappa, K. S. (2023). A new triazolyl‐indolo‐quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPεC. Drug Development Research. https://doi.org/10.1002/ddr.22117
Vancouver
Suresh RN, Jung YY, Mohan CD, Gowda SV, Harsha KB, Mantelingu K, et al. A new triazolyl‐indolo‐quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPεC. Drug Development Research. 2023. doi:10.1002/ddr.22117
BibTeX
@article{Suresh2023,
author = {Suresh, Rajaghatta N and Jung, Young Y and Mohan, Chakrabhavi D and Gowda, Shalini V and Harsha, Kachigere B and Mantelingu, Kempegowda and Sethi, Gautam and Ahn, Kwang S and Rangappa, Kanchugarakoppal S},
title = {A new triazolyl‐indolo‐quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPεC},
journal = {Drug Development Research},
year = {2023},
doi = {10.1002/ddr.22117}
}
EUVIMED